Carregant...
Rituximab use for refractory anti-HMGCR immune-mediated necrotizing myopathy: A case report
Immunosuppression is the cornerstone therapy for anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase (anti-HMGCR) myopathy. Typical immunosuppressants such as corticosteroids, methotrexate, and azathioprine have been used in conjunction with removal of the offending agent, yet the use of rituximab...
Guardat en:
| Publicat a: | Intractable Rare Dis Res |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
International Research and Cooperation Association for Bio & Socio-Sciences Advancement
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8122313/ https://ncbi.nlm.nih.gov/pubmed/33996358 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5582/irdr.2020.03144 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|